Dr. Bruce R. Kava, MD

Dr. Kava practices at UMiami Medicine - Urology in Miami, Florida.

Dr. Kava's NPI, 1265461826, was assigned on July 3, 2006. Dr. Kava graduated from Albert Einstein College of Medicine in 1989. Dr. Kava holds Florida license ME72882.

Dr. Kava's primary practice is UMiami Medicine - Urology, at 1150 Nw 14th St, Miami, FL 33136 in Miami-Dade County. The practice phone is (305) 243-7688.

Dr. Kava's primary practice is UMiami Medicine - Urology in Miami, Florida. Dr. Kava is also affiliated with Jackson Memorial Hospital. The medical group on file is University of Miami Health System. Dmand AI also links Dr. Kava to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kava practices, 2 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Kava's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Kava is board certified in urology by the American Board of Urology. Dr. Kava is licensed in Florida.

Dmand AI lists bladder disease, bladder removal, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery and kidney stone disease among the conditions Dr. Kava treats.

CMS data shows 2,633 Medicare services from Dr. Kava across 19 procedure codes in 2024, for 854 Medicare patients. Medicare paid $164,681 for them.

CMS counts 854 Medicare patients who saw Dr. Kava in 2024. The largest group is 65 to 74, with 399 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.37, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kava's median patient age at 71, with 9% women.

In 2024, Dr. Kava wrote 2,437 Medicare Part D claims for 676 patients. 86% of them were for generic drugs. CMS names the drug for 2,250 of them, across 26 drugs with 11 or more claims each, at $548,172 in total drug cost. In 2023, CMS named 2,003 claims across 28 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Kava for performance year 2024, reported as part of a group. Dr. Kava accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kava as offering telehealth. CMS counts 11 procedures of prostate resection by Dr. Kava, more than 60% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of the uterus: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 71 papers to Dr. Kava, published from 2007 to 2025. 2016 was the busiest year, with 5. The most frequent topics are Prostatic Neoplasms, Prostate and Erectile Dysfunction. Dr. Kava has published most often in J Sex Med. Dr. Kava's most frequent co-authors are Murugesan Manoharan, MD, Mark S. Soloway, MD and Dipen J. Parekh, MD.

Dmand AI links Dr. Kava to 5 clinical trials. Conditions studied include Prostatic Neoplasms, Prostatic Diseases and Ileus. University of Miami sponsors the most, 3.

CMS Open Payments shows 495 general payments to Dr. Kava from 33 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 67% of the total. Merit Medical Systems Inc paid the most, $120,481.

Dmand AI lists 4 awards for Dr. Kava, most recently Top Doctors:South Florida in 2016.

Dr. Kava graduated from Albert Einstein College of Medicine in 1989. Dr. Kava is a member of ACS.

Dr. Kava is in network with 11 carriers, including Elevance, Aetna and United Healthcare. PPO plans come from the most carriers, 7. Check the plan with the practice before a visit.